Toxicity and antidotal treatment by synthesized and optimized ferric(III) hexacyanoferrate(II) for thallium

Toxicity and antidotal treatment by synthesized and optimized ferric(III) hexacyanoferrate(II) for thallium

Abstract Background The active pharmaceutical ingredient (API) of USFDA-approved Radiogardase®-Cs capsule is ferric(III) hexacyanoferrate(II) which is commonly known as Prussian blue insoluble (PB). It enhances the elimination of radioactive or non-radioactive caesium/thallium (Cs(I)/Tl(I)) from the...

Full description

Bibliographic Details
Main Authors: Vivek Kumar, Dharam Pal Pathak, Nidhi Sandal
Format: Article
Language:English
Published: SpringerOpen 2023-07-01
Series:Bulletin of the National Research Centre
Subjects:
Toxicity
Radiogardase®-Cs
Thallium
PB insoluble
Decorporation
In vivo
Online Access:https://doi.org/10.1186/s42269-023-01086-x

Internet

https://doi.org/10.1186/s42269-023-01086-x

Similar Items